{"altmetric_id": 82918542, "counts": {"readers": {"citeulike": "0", "mendeley": "62", "connotea": "0"}, "total": {"posts_count": 13}, "twitter": {"unique_users_count": 10, "posts_count": 10}, "patent": {"unique_users_count": 3, "unique_users": ["patent:US-10787501-B1", "patent:US-10954289-B1", "patent:US-10975139-B1"], "posts_count": 3}}, "citation": {"altmetric_jid": "532721422a83ee84788b4567", "authors": ["Vandergaast, Rianna", "Carey, Timothy", "Reiter, Samantha", "Lech, Patrycja", "Gnanadurai, Clement", "Tesfay, Mulu", "Buehler, Jason", "Suksanpaisan, Lukkana", "Naik, Shruthi", "Brunton, Bethany", "Recker, Jordan", "Haselton, Michelle", "Ziegler, Christopher", "Roesler, Anne", "Mills, John R.", "Theel, Elitza", "Weaver, Scott C.", "Rafael, Grace", "Roforth, Matthew M.", "Jerde, Calvin", "Tran, Sheryl", "Diaz, Rosa Maria", "Bexon, Alice", "Baum, Alina", "Kyratsous, Christos A.", "Peng, Kah Whye", "Russell, Stephen J."], "doi": "10.1101/2020.05.26.117549", "first_seen_on": "2020-05-28T05:04:12+00:00", "issns": [], "journal": "bioRxiv", "last_mentioned_on": 1618272000, "links": ["https://www.biorxiv.org/content/10.1101/2020.05.26.117549v1", "https://doi.org/10.1101/2020.05.26.117549"], "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/05/27/2020.05.26.117549.full.pdf", "pmid": "32577655", "publisher": "Cold Spring Harbor Laboratory", "title": "Development and validation of IMMUNO-COV\u2122: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/84afc304-45cb-37aa-81a3-07ea1569af1e/"}, "altmetric_score": {"score": 7.35, "score_history": {"1y": 7.35, "6m": 4, "3m": 4, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 7.35}, "context_for_score": {"all": {"total_number_of_other_articles": 17674883, "mean": 9.4355274911831, "rank": 3088856, "this_scored_higher_than_pct": 82, "this_scored_higher_than": 14579017, "rank_type": "exact", "sample_size": 17674883, "percentile": 82}, "similar_age_3m": {"total_number_of_other_articles": 294049, "mean": 20.267257803971, "rank": 75793, "this_scored_higher_than_pct": 74, "this_scored_higher_than": 218075, "rank_type": "exact", "sample_size": 294049, "percentile": 74}, "this_journal": {"total_number_of_other_articles": 120556, "mean": 13.883411128439, "rank": 49585, "this_scored_higher_than_pct": 58, "this_scored_higher_than": 70810, "rank_type": "exact", "sample_size": 120556, "percentile": 58}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 8225, "mean": 18.310486808511, "rank": 3377, "this_scored_higher_than_pct": 58, "this_scored_higher_than": 4838, "rank_type": "exact", "sample_size": 8225, "percentile": 58}}}, "demographics": {"poster_types": {"member_of_the_public": 8, "researcher": 2}, "users": {"twitter": {"cohorts": {"Members of the public": 8, "Scientists": 2}}, "mendeley": {"by_status": {"Professor > Associate Professor": 1, "Researcher": 8, "Student  > Master": 7, "Student  > Ph. D. Student": 4, "Professor": 1, "Student  > Bachelor": 7, "Student  > Doctoral Student": 1, "Lecturer": 3, "Other": 11, "Librarian": 5, "Lecturer > Senior Lecturer": 1, "Unspecified": 1}, "by_discipline": {"Medicine and Dentistry": 25, "Mathematics": 1, "Pharmacology, Toxicology and Pharmaceutical Science": 1, "Environmental Science": 1, "Unspecified": 2, "Engineering": 1, "Neuroscience": 2, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 2, "Agricultural and Biological Sciences": 1, "Nursing and Health Professions": 5, "Biochemistry, Genetics and Molecular Biology": 7, "Veterinary Science and Veterinary Medicine": 1}}}, "geo": {"twitter": {"US": 4}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "1949132852"}, "tweet_id": "1265871383277559813"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "1054460958226157568"}, "tweet_id": "1265871384229687297"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "389104963"}, "tweet_id": "1265872357253623809"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "747980614708531201"}, "tweet_id": "1265873755743703041"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "946741899800522752"}, "tweet_id": "1265915587437477888"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "818534692362289152"}, "tweet_id": "1266001583072034822"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "1118320478257422338"}, "tweet_id": "1266175243162271746"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "3116670013"}, "tweet_id": "1278518960732860416"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "3824923812"}, "tweet_id": "1278519441836269571"}, {"license": "gnip", "citation_ids": [82918542], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1370834642606067714"}], "patent": [{"title": "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10787501-B1", "license": "public", "citation_ids": [81686823, 79886706, 83946256, 81839528, 81950522, 78627096, 82099898, 84234572, 82123095, 81432678, 81687333, 84590251, 82776439, 82125287, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 82372636, 83326754, 83146578, 82236864, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 83816209, 76759624, 82241906, 82006689, 82127390, 83471779, 81898802, 82752495, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 79411573, 82846613, 84064050, 82136174, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 89309738, 92789824, 93046290, 42295981, 2000877, 4443560, 1927968, 4498119, 80912392], "posted_on": "2020-09-29T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10787501-B1", "jurisdiction": "US", "filing_status": "Grant"}, {"title": "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10954289-B1", "license": "public", "citation_ids": [81687333, 84590251, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 81686823, 79886706, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 82372636, 83326754, 83146578, 82236864, 83946256, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 82776439, 82125287, 83816209, 76759624, 4225088, 82241906, 82006689, 82127390, 84234572, 82123095, 81839528, 83471779, 81898802, 82752495, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 79411573, 81331345, 82846613, 84064050, 82136174, 81432678, 81950522, 78627096, 82099898, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 76348331, 78651983, 89309738, 86397980, 92789824, 83360939, 93046290, 42295981, 83349805, 84959013, 2000877, 79801422, 76810504, 4443560, 82104617, 1927968, 4498119, 80912392], "posted_on": "2021-03-23T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10954289-B1", "jurisdiction": "US", "filing_status": "Grant"}, {"title": "Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments", "url": "https://app.dimensions.ai/details/patent/US-10975139-B1", "license": "public", "citation_ids": [81687333, 84590251, 83554448, 81899235, 84064023, 82227840, 82300885, 80174942, 82527991, 81686823, 79886706, 99920692, 81757531, 82060698, 84573721, 81625616, 85059707, 82124185, 82449157, 82595199, 83326754, 83146578, 82236864, 83946256, 81550014, 82750447, 78284411, 50982232, 83947308, 4498119, 82312840, 82447592, 82059207, 83819478, 83493208, 82526969, 83325716, 82683654, 83490745, 82776439, 82125287, 83816209, 76759624, 82241906, 82006689, 82127390, 84234572, 82123095, 81839528, 83471779, 81898802, 82752495, 4225088, 83470627, 82595623, 82918542, 82373603, 81317927, 84026513, 81331345, 82846613, 84064050, 82136174, 81432678, 81950522, 78627096, 82099898, 82398872, 82371737, 82526610, 78206570, 82592966, 82006659, 80912392, 78976480, 89122343, 76348331, 78651983, 89309738, 86397980, 92789824, 83360939, 93046290, 42295981, 83349805, 84959013, 2000877, 79801422, 76810504, 4443560, 82104617, 1927968, 4498119, 80912392], "posted_on": "2021-04-13T00:00:00+00:00", "summary": "The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infecti", "ucid": "US-10975139-B1", "jurisdiction": "US", "filing_status": "Grant"}]}, "score": 7.35, "images": {"small": "https://badges.altmetric.com/?size=64&score=8&types=aatttttt", "medium": "https://badges.altmetric.com/?size=100&score=8&types=aatttttt", "large": "https://badges.altmetric.com/?size=180&score=8&types=aatttttt"}}